<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/molecule_pages/rss"/>
    <ttl>720</ttl>
    <title>Recent molecule_pages items</title>
    <link>https://escholarship.org/uc/molecule_pages/rss</link>
    <description>Recent eScholarship items from UCSD Molecule Pages</description>
    <pubDate>Fri, 15 May 2026 12:43:47 +0000</pubDate>
    <item>
      <title>H-Ficolin</title>
      <link>https://escholarship.org/uc/item/9kg406tx</link>
      <description>H-ficolin is a serum lectin synthesized (as a ~34 kDa polypeptide) predominantly by the liver and lung tissues and is one of the soluble pattern recognition receptors of the innate immune system. It is structurally similar to &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004266"&gt;L-&lt;/a&gt; and &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004265"&gt;M-&lt;/a&gt; ficolins, but is different in its tissue expression and binding affinities to pathogenic ligands. Ficolins have an amino (N)-terminal cysteine-rich region, a middle stretch of a collagen-like sequence, and a fibrinogen-like domain in the carboxy (C)-terminus. Three identical polypeptides form a structural (triple helical) subunit, with the help of the collagen-like domain. Further oligomerization of this subunit results in different sized H-ficolin molecules in circulation. The polypeptides in the structural subunit are cross-linked by disulphide bonds in the N-terminal region and the fibrinogen-like...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9kg406tx</guid>
      <pubDate>Fri, 31 Jan 2014 00:00:00 +0000</pubDate>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Cedzynski, Maciej</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>Complement C2</title>
      <link>https://escholarship.org/uc/item/8jq4x8hs</link>
      <description>Complement C2 is a single chain serum glycoprotein (110 kDa), which serves as the catalytic subunit of C3 and C5 convertases in the classical and lectin pathways. During complement activation, C2 is cleaved by classical (&lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004233"&gt;C1s&lt;/a&gt;) or lectin (MBL-associated serine protease-2; &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004275"&gt;MASP-2&lt;/a&gt;) proteases into two fragments: C2b and C2a. C2a, a serine protease, in complex with C4b fragment of complement factor &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004237"&gt;C4&lt;/a&gt;, generates the C3 (C4b2a) or C5 (C4b2a3b) convertase. C3 convertase is very short-lived and cleaves complement &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004235"&gt;C3&lt;/a&gt; into C3a and C3b fragments (selective cleavage of Arg-|-Ser bond in C3 alpha-chain). C3 convertase requires the presence of magnesium and decays over time at physiologic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8jq4x8hs</guid>
      <pubDate>Fri, 31 Jan 2014 00:00:00 +0000</pubDate>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Inal, Jameel</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>MASP-3</title>
      <link>https://escholarship.org/uc/item/7xx5t910</link>
      <description>MASP-3 (mannose/mannan binding lectin (MBL) associated serine protease-3) is ~82 kDa protein generated through alternative splicing of the &lt;em&gt;MASP1&lt;/em&gt; gene. This gene also generates &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004274"&gt;MASP-1&lt;/a&gt; and &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A008392"&gt;MAp44&lt;/a&gt; proteins. MASP-3 is bound to multimeric forms of pathogen receptors, such as &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004276"&gt;MBL&lt;/a&gt; and the three ficolins. MASP-3 has two CUB, a calcium-binding EGF-like, a trypsin-like serine protease and two complement control protein (CCP) domains. The serine protease domain however, is not known to be active and does not act on substrates of either MASP-1 or &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004275"&gt;MASP-2&lt;/a&gt;. Instead, it competes with MASP-1 and MASP-2 to bind to MBL and therefore plays a regulatory role in the lectin pathway of complement...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7xx5t910</guid>
      <pubDate>Fri, 31 Jan 2014 00:00:00 +0000</pubDate>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Matsushita, Misao</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>Integrin beta-2</title>
      <link>https://escholarship.org/uc/item/6s87779x</link>
      <description>Integrins are heterodimeric transmembrane (TM) glycoproteins containing one each of α and β subunit, which are held together by non-covalent forces. Integrin β2 (CD18) is the β subunit for four heterodimers: αDβ2, αXβ2, αMβ2 and αLβ2. Integrin β2 family plays an essential role in leukocyte recruitment and activation during inflammation. Structurally, while most part of the αβ dimer is extracellular, both the subunits traverse the plasma membrane and terminate as short cytoplasmic domains. Each heterodimeric integrin exists on the cell surface mainly in an inactive (bent) form until they receive stimulating signals from other receptors (&lt;em&gt;via&lt;/em&gt; inside-out signaling), and the end result of integrin activation is a shift in integrin conformation from a bent to an extended one. The binding of cytoplasmic proteins to α- and/or β-subunit carboxy-terminal tails is an essential part of the activation process, as these interactions stabilize the extended integrin conformation and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6s87779x</guid>
      <pubDate>Fri, 31 Jan 2014 00:00:00 +0000</pubDate>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Hajishengallis, George</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>MASP-2</title>
      <link>https://escholarship.org/uc/item/65r091gb</link>
      <description>MASP-2 (mannose/mannan binding lectin (MBL) associated serine protease-2) is a serum protein predominantly synthesized by the liver as a ~75kDa protein and is one of the key molecules of the innate immune system. It is mainly bound to multimeric protein complexes, such as &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004276&amp;amp;type=molpage"&gt;MBL&lt;/a&gt;, the three ficolins (&lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004265&amp;amp;type=molpage"&gt;M-ficolin&lt;/a&gt;, &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004266&amp;amp;type=molpage"&gt;L-ficolin&lt;/a&gt; and &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004267&amp;amp;type=molpage"&gt;H-ficolin&lt;/a&gt;) and collectin kidney 1 (CL-K1, alias CL-11). These complexes serve as pathogen receptors, which are further bound to &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004274&amp;amp;type=molpage"&gt;MASP-1&lt;/a&gt;, a serine protease. Binding of these complexes to their appropriate...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/65r091gb</guid>
      <pubDate>Fri, 31 Jan 2014 00:00:00 +0000</pubDate>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Thielens, Nicole</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>MASP-1</title>
      <link>https://escholarship.org/uc/item/59j8260z</link>
      <description>MASP-1 (mannose/mannan binding lectin associated serine protease-1) is a serum protein (~79kDa poylpeptide) predominantly synthesized by the liver. It is an important player in the innate immune system and is mainly bound to multimeric pathogen recognition receptors such as &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004276"&gt;mannose/mannan-binding lectin (MBL)&lt;/a&gt; and the three ficolins (&lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004265"&gt;M-ficolin&lt;/a&gt;, &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004266"&gt;L-ficolin&lt;/a&gt; and &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004267"&gt;H-ficolin&lt;/a&gt;). MASP-1 has two CUB, a calcium-binding EGF-like, a trypsin-like serine protease and two complement control protein (CCP) domains. The serine protease domain is auto-activated upon binding of these receptors to their appropriate pathogenic ligands, generally carbohydrate domains or acetylated sugar residues. MASP-1...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/59j8260z</guid>
      <pubDate>Fri, 31 Jan 2014 00:00:00 +0000</pubDate>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Matsushita, Misao</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>MAp44</title>
      <link>https://escholarship.org/uc/item/4028n4n3</link>
      <description>&lt;p&gt;MAp44 is a ~44 kDa alternate splice product of &lt;em&gt;MASP1&lt;/em&gt; and is mainly expressed in the heart. Mannose/mannan binding lectin (MBL) associated serine proteases, &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004274"&gt;MASP-1&lt;/a&gt; and &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A008391"&gt;MASP-3&lt;/a&gt; are other products of &lt;em&gt;MASP1&lt;/em&gt;. Similar to MASP-1 (isoform 1 of &lt;em&gt;MASP1&lt;/em&gt;, which represents the longest transcript), MAp44 has a C1r/C1s/Uegf/bmp1 (CUB) domain, calcium-binding EGF-like domain and complement control protein (CCP) domains. However, it lacks the serine protease domain of MASP-1 and therefore cannot perform MASP-1's functions. MAp44 binds to multimeric pathogen receptors such as&lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004276"&gt;MBL&lt;/a&gt; and the three ficolins, and is believed to play a regulatory role in the lectin pathway of complement activation.&lt;/p&gt;</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4028n4n3</guid>
      <pubDate>Fri, 31 Jan 2014 00:00:00 +0000</pubDate>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Matsushita, Misao</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>A peer reviewed journal with structured data</title>
      <link>https://escholarship.org/uc/item/0f78165p</link>
      <description>The Molecule Pages from UCSD Signaling Gateway have been regularly published online since one decade and are now printed biannually. As a researcher involved in biomathematical and biomechanical modeling and simulation, I found these pages very informative, either when dealing with biological processes happening at the nano- and microscopic scales, or incorporating these events in a meso- and macroscopic scale modeling to enhance reductionist models when necessary. UCSD Molecule Pages indeed yield information that enables interdisciplinary research and I have cited the Molecule Pages over 130 times in my recent book ‘Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems’ (Springer New York, 2013).</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0f78165p</guid>
      <pubDate>Mon, 17 Jun 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Thiriet, Marc</name>
      </author>
    </item>
    <item>
      <title>p38 beta MAP kinase</title>
      <link>https://escholarship.org/uc/item/9567563t</link>
      <description>In mammals, there are four p38 protein kinases: p38α, p38β, p38γ and p38δ. p38β was identified in 1996 as a closely related protein kinase of p38α, sharing 74% sequence identity and the Thr-Gly-Tyr dual phosphorylation motif characteristic of all p38 MAPKs. p38β is widely distributed in cells and tissues, but less so than p38α; p38β is particularly abundant in endothelial cells. p38β is activated &lt;em&gt;in vivo &lt;/em&gt;by dual phosphorylation at Thr180 and Tyr182 by the MAP2K, MKK3 and MKK6 in response to a multitude of stimuli including environmental stressors, cytokines and growth factors. p38β can be dephosphorylated on both its Thr and Tyr residues by Dual-Specificity Phosphatases. p38β, like p38α, is targeted by a class of pyridinyl imidazole drugs that do not target the other two p38 MAPKs. These compounds were invaluable in discovering functions regulated by p38α and p38β. However, they do not permit to distinguish functions mediated by p38β from those regulated by p38α. This...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9567563t</guid>
      <pubDate>Mon, 10 Jun 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Rousseau, Simon</name>
      </author>
    </item>
    <item>
      <title>L-Ficolin</title>
      <link>https://escholarship.org/uc/item/7sf902jf</link>
      <description>&lt;p&gt;L-ficolin is a serum lectin synthesized (as a ~37 kDa polypeptide) predominantly by the liver, and is one of the key molecules of the innate immune system. It has an amino (N)-terminal cysteine-rich region, a middle stretch of a collagen-like sequence, and a fibrinogen-like domain in the carboxy (C)-terminus. Three identical polypeptides form a structural (triple helical) subunit, with the help of the collagen-like domain. Further oligomerization of this subunit results in different sized L-ficolin molecules (from dimers to tetramers) in circulation. However, the tetrameric form (composed of 12 polypeptides) is the most prevalent structure. The polypeptides in the structural subunit are cross-linked by disulphide bonds in the N-terminal region. The fibrinogen-like domain forms a globular structure. The overall structure of oligomeric L-ficolin closely resembles mannose-binding lectin (MBL). Similar to MBL, L-ficolin also acts as a pattern recognition receptor. It primarily...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7sf902jf</guid>
      <pubDate>Mon, 10 Jun 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Thiel, Steffen</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>Mannose/mannan-binding lectin</title>
      <link>https://escholarship.org/uc/item/6pf767sn</link>
      <description>&lt;p&gt;Mannose/mannan-binding lectin (MBL) is a serum lectin synthesized (as a ~32 kDa peptide) by the liver and is one of the key molecules of the innate immune system. Each peptide has an N (amino)-terminal cysteine-rich region, a middle stretch of a collagen-like sequence, and a carbohydrate recognition domain (CRD) in the C (carboxy)-terminus. Three identical peptides form a structural subunit, similar to a collagenous triple helix, which is the basic building block of all circulating molecular forms of MBL. Further oligomerization of these structural subunits by disulphide bonds in the N-terminal region results in MBL molecules of different sizes (from dimers to hexamers), but the hexameric form is probably the most common. MBL-associated serine proteases (MASPs) bind to MBL multimeric forms to stabilize the molecule. MBL is a pattern-recognition receptor and the CRDs of MBL serve to bind to a wide range of pathogens such as bacteria, viruses and protozoa, by recognizing carbohydrate...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6pf767sn</guid>
      <pubDate>Mon, 10 Jun 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Fujita, Teizo</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>Tsh receptor</title>
      <link>https://escholarship.org/uc/item/4c80d87m</link>
      <description>&lt;p&gt;The TSH receptor is a member of the G protein-coupled receptor(GPCR)family. It is one of the glycoprotein hormone receptors, which also includes the FSH and LH/CG receptors. The TSH receptor mediates the action of the pituitary-derived glycoprotein, TSH (thyroid stimulating hormone, thyrotropin or thyrotrophin). TSH binds to the TSH receptor which is located on thyroid follicular cells (but is also expressed in extrathyroidal sites). Glycosylation of the TSH receptor occurs, as does cleavage of the receptor from an intact to an extracellular form (α subunit), which may be shed after deletion of a short region (aa 316-366) near the C terminal of the extracellular domain, thus leaving a transmembrane form (β subunit). The α subunit is responsible for ligand/autoantibody binding, facilitated by glycosylation and possibly by the extracellular loops of the 7 transmembrane segments. The intracellular loops of the β subunit interact with G proteins when the receptor is activated....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4c80d87m</guid>
      <pubDate>Mon, 10 Jun 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Frauman, Albert</name>
      </author>
    </item>
    <item>
      <title>Leukocyte surface antigen CD47</title>
      <link>https://escholarship.org/uc/item/05m062m2</link>
      <description>CD47, also known as integrin-associated protein (IAP), ovarian cancer antigen OA3, Rh-related antigen and MER6, is a widely expressed transmembrane receptor belonging to the immunoglobulin superfamily. CD47 is the counter-receptor for two members of the signal-regulatory protein (SHPS/SIRP) family and a high-affinity receptor for the secreted protein thrombospondin-1. Interactions with SIRP receptors play roles in self recognition and regulation of innate immune responses. Over-expression of CD47 on some cancers is a negative prognostic factor and protects against innate immune surveillance. Engagement of CD47 on vascular cells by thrombospondin-1 regulates calcium, cAMP, and nitric oxide/cGMP signaling pathways that control blood pressure, tissue perfusion, and angiogenesis. Moreover, CD47 signaling in various cell types regulates pathways that can trigger cell death, limit stem cell self-renewal, regulate mitochondrial homeostasis and other differentiation pathways, and activate...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/05m062m2</guid>
      <pubDate>Mon, 10 Jun 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Soto Pantoja, David R</name>
      </author>
      <author>
        <name>Kaur, Sukhbir</name>
      </author>
      <author>
        <name>Miller, Thomas W</name>
      </author>
      <author>
        <name>Isenberg, Jeffrey S</name>
      </author>
      <author>
        <name>Roberts, David D</name>
      </author>
    </item>
    <item>
      <title>Cdc7l1</title>
      <link>https://escholarship.org/uc/item/9rh6t1tx</link>
      <description>Cdc7 (Cell division cycle 7), also known as Hsk1 in fission yeast, is an important serine/threonine kinase, whose sequence is conserved from yeasts to mammals. The kinase activity of Cdc7 is regulated during the cell cycle by an activation subunit Dbf4 (also known as Dfp1/Him1 in fission yeast and ASK in mammals,) via heterodimer formation between the two. Cdc7 was first identified in budding yeast as a temperature-sensitive mutant (cdc7&lt;sup&gt;
  &lt;em&gt;ts&lt;/em&gt;
&lt;/sup&gt;) defective in cell cycle progression. The budding yeast cdc7&lt;sup&gt;
  &lt;em&gt;ts&lt;/em&gt;
&lt;/sup&gt; cells arrest immediately before the onset of S phase at the non-permissive temperature, but resume growth and complete S phase in the absence of ongoing protein synthesis upon return to the permissive temperature. Cdc7 plays a conserved, pivotal role in triggering origin firing through phosphorylation of MCM (mini-chromosome maintenance) proteins. It facilitates the loading of Cdc45 and other replisome factors onto the pre-replicative...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9rh6t1tx</guid>
      <pubDate>Tue, 28 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Toh, Gaik Theng</name>
      </author>
      <author>
        <name>Masai, Hisao</name>
      </author>
    </item>
    <item>
      <title>Complement C1q subcomponent subunit A</title>
      <link>https://escholarship.org/uc/item/9663z86s</link>
      <description>Complement C1q subcomponent subunit A (C1qA) is one of the three components of C1q molecule. Functional C1q is composed of eighteen polypeptide chains: six C1qA chains, six &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004229"&gt;C1qB &lt;/a&gt;chains, and six &lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004230"&gt;C1qC&lt;/a&gt; chains, which are arranged as six heterotrimers of ABC: (ABC)&lt;sub&gt;6&lt;/sub&gt;. Each of the individual C1q polypeptide chain consists of a N-terminal region and a C-terminal globular region (gC1q), of ~135 residues. Each N-terminal consists of 2-11 amino acid segments containing a half-cysteine residue that is involved in formation of inter-chain disulphide bonds, followed by a collagen-like region (CLR) consisting of ~81 residues. The collagen-like regions in A, B and C chains of each heterotrimer come together to form a triple helical collagen like structure. Further, A and B chains in each heterotrimer are bound by a disulphide bond,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9663z86s</guid>
      <pubDate>Tue, 28 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Dinasrapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Tenner, Andrea J</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>Inaugural issue of UCSD Molecule Pages</title>
      <link>https://escholarship.org/uc/item/8tf9h4z8</link>
      <description>&lt;p&gt;We are pleased to launch the inaugural issue of the&lt;/p&gt; &lt;em&gt;
  &lt;em&gt;UCSD Molecule Pages&lt;/em&gt;
&lt;/em&gt;
      &lt;p&gt;. While the Molecule Pages themselves have been regularly published online since 2003, we have now taken a step ahead by compiling these publications in a bi-annual journal format.&lt;/p&gt;
      &lt;p&gt; &lt;/p&gt;
      &lt;p&gt;
      &lt;/p&gt;&lt;p&gt;Each Molecule Page, based on a cell signaling protein, combines expert authored reviews describing the biological activity, regulation and localization of the protein with curated, highly-structured data (e.g. protein interactions) and automatic annotation from publicly available data sources (e.g. UniProt and Genbank).&lt;/p&gt;
      &lt;p&gt; &lt;/p&gt;</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8tf9h4z8</guid>
      <pubDate>Tue, 28 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Lambris, John</name>
      </author>
    </item>
    <item>
      <title>Complement C5</title>
      <link>https://escholarship.org/uc/item/76k5d1mt</link>
      <description>Complement C5 is a 189 kDa protein synthesized in liver as a single-chain precursor molecule. The precursor molecule is then cleaved to a disulfide linked two-chain glycoprotein consisting of a 115 kDa (C5α) and a 75 kDa N-terminal (C5β) chain. C5 is present in all the three known complement activation pathways: classical, alternative and lectin. C5α chain is cleaved by C5 convertases, which are formed during the complement activation process, to form C5a (74 a.a long) and C5α' chain (925 a.a long). C5α' chain and C5β chain (655 a.a. long) together form C5b. C5a is a major anaphylotoxin involved in chemotaxis of neutrophils and release of pro-inflammatory cytokines. These functions of C5a require binding to its receptor, C5aR. C5b sequentially recruits C6, C7, C8 and C9 in a non-enzymatic manner to form the terminal complement complex (TCC, also called membrane attack complex or MAC). TCC forms a lytic pore in the target membrane and kills the pathogen. While the functions of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/76k5d1mt</guid>
      <pubDate>Tue, 28 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Isenman, David E.</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>WAVE2</title>
      <link>https://escholarship.org/uc/item/4s96w6n2</link>
      <description>&lt;p&gt;WASP family verprolin-homologous protein 2 (WAVE2, also called WASF2) was originally identified by its sequence similarity at the carboxy-terminal VCA (verprolin, cofilin/central, acidic) domain with Wiskott-Aldrich syndrome protein (WASP) and N-WASP (neural WASP). In mammals, WAVE2 is ubiquitously expressed, and its two paralogs, WAVE1 (also called suppressor of cAMP receptor 1, SCAR1) and WAVE3, are predominantly expressed in the brain. The VCA domain of WASP and WAVE family proteins can activate the actin-related protein 2/3 (Arp2/3) complex, a major actin nucleator in cells. Proteins that can activate the Arp2/3 complex are now collectively known as nucleation-promoting factors (NPFs), and the WASP and WAVE families are a founding class of NPFs.&lt;/p&gt;&lt;p&gt;The WAVE family has an amino-terminal WAVE homology domain (WHD domain, also called the SCAR homology domain, SHD) followed by the proline-rich region that interacts with various Src-homology 3 (SH3) domain proteins. The VCA...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4s96w6n2</guid>
      <pubDate>Tue, 28 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Takenawa, Tadaomi</name>
      </author>
      <author>
        <name>Suetsugu, Shiro</name>
      </author>
      <author>
        <name>Yamazaki, Daisuke</name>
      </author>
      <author>
        <name>Kurisu, Shusaku</name>
      </author>
    </item>
    <item>
      <title>Complement factor H</title>
      <link>https://escholarship.org/uc/item/4400c856</link>
      <description>&lt;p&gt;Complement factor H (fH) is a single chain plasma glycoprotein (approximately 150 kDa in size), with 20 domains termed complement control protein (CCP) domains or short consensus repeats (SCR). The complement factor H gene (CFH) is located on chromosome 1q32 in the regulators of complement activation (RCA) gene cluster, adjacent to the genes that code for the Complement factor H-Related Proteins (CFHRs). The RCA cluster includes additional regulators containing SCR domains, such as C4 Binding Protein (&lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004239"&gt;C4BP&lt;/a&gt;), Complement receptor type 1 (&lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004261"&gt;CR1&lt;/a&gt;), Complement decay-accelerating factor (&lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004251"&gt;DAF&lt;/a&gt;), Membrane cofactor protein (&lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004250"&gt;MCP&lt;/a&gt;). fH and C4BP are fluid-phase (soluble) complement regulators,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4400c856</guid>
      <pubDate>Tue, 28 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Jozsi, Mihaly</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>Complement C3</title>
      <link>https://escholarship.org/uc/item/07h8p9hg</link>
      <description>&lt;p&gt;Complement C3 is the central component of the human complement system. It is ~186 kDa in size, consisting of an α-chain (~110 kDa) and a β-chain (~75 kDa) that are connected by cysteine bridges. C3 in its native form is inactive. Cleavage of C3 into C3b (~177 kDa) and C3a (~9 kDa) is a crucial step in the complement activation cascade, which can be initiated by one or more of the three distinct pathways, called alternative, classical and lectin complement pathways. In the alternative pathway, hydrated C3 (C3&lt;sub&gt;(H20)&lt;/sub&gt;) recruits complement factor B (&lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004254"&gt;fB&lt;/a&gt;), which is then cleaved by complement factor D (&lt;a href="http://www.signaling-gateway.org/molecule/query?afcsid=A004255"&gt;fD&lt;/a&gt;) to result in formation of the minor form of C3-convertase (C3&lt;sub&gt;(H20)&lt;/sub&gt;Bb) that cleaves C3 into C3a and C3b. A small percent of the resulting C3b is rapidly deposited (opsonization through covalent bond) in the immediate...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/07h8p9hg</guid>
      <pubDate>Tue, 28 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Dinasarapu, Ashok Reddy</name>
      </author>
      <author>
        <name>Chandrasekhar, Anjana</name>
      </author>
      <author>
        <name>Sahu, Arvind</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
    </item>
    <item>
      <title>Inaugural issue of UCSD Molecule Pages</title>
      <link>https://escholarship.org/uc/item/7zj7x62f</link>
      <description>&lt;p&gt;We are pleased to launch the inaugural issue of the&lt;/p&gt;&lt;p&gt;
  &lt;em&gt;
    &lt;em&gt;UCSD Molecule Pages&lt;/em&gt;
  &lt;/em&gt;
&lt;/p&gt;&lt;p&gt; &lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;.&lt;/p&gt;</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7zj7x62f</guid>
      <pubDate>Thu, 16 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Lambris, John</name>
      </author>
    </item>
    <item>
      <title>Numb</title>
      <link>https://escholarship.org/uc/item/60q1p5j6</link>
      <description>Mammalian Numb (Numb) encodes an endocytic adaptor protein first characterized in the &lt;em&gt;Drosophila&lt;/em&gt; nervous system as an intrinsic cell fate determinant which is asymmetrically localized and preferentially segregates into only one of the two daughter cells upon division (Rhyu &lt;em&gt;et al&lt;/em&gt;. 1994; Knoblich &lt;em&gt;et al&lt;/em&gt;. 1995; Spana and Doe 1995). Mammalian Numb homologues have been identified, and homozygous deletion of Numb in mice leads to embryonic lethality, suggesting that Numb plays an essential role in mammalian development (Verdi &lt;em&gt;et al&lt;/em&gt;. 1996; Zhong &lt;em&gt;et al&lt;/em&gt;. 1996). In addition to playing a role in asymmetric cell division(ACD), Numb has been shown to function in endocytosis, ubiquitination, cell adhesion, migration, and cancer.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/60q1p5j6</guid>
      <pubDate>Tue, 14 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Krieger, Jonathan R</name>
      </author>
      <author>
        <name>McGlade, C J</name>
      </author>
    </item>
    <item>
      <title>Smurf1</title>
      <link>https://escholarship.org/uc/item/22p755nb</link>
      <description>The Smad Ubiquitination Regulatory Factor-1, or Smurf1, is an E3 ubiquitin ligase that catalyzes mono- or polyubiquitylation of protein targets which primarily function in TGFβ signaling pathways, but also include a growing list of substrates encompassing other molecular pathways and cellular processes distinct from TGFβ pathways. Smurf1 and a close homolog, Smurf2, are E3 ubiquitin ligases that belong to a small family of proteins distinguished by the presence of a catalytic, C-terminal region that is known as the HECT domain, for Homologous to E6AP C-Terminus. This region of the Smurfs and other HECT E3s form a covalent intermediate with ubiquitin (Ub) and subsequently transfer the Ub moiety to a substrate protein whose selection and targeting are governed by either direct interaction with Smurf1, or in concert with an adaptor protein(s) that bridges Smurf1 and the substrate. Smurf1 can operate throughout the cell and has a wide variety of protein targets, reflecting the diversity...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/22p755nb</guid>
      <pubDate>Tue, 14 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Thompsen, Gerald H</name>
      </author>
    </item>
    <item>
      <title>Phosphodiesterase 8A, cAMP-specific</title>
      <link>https://escholarship.org/uc/item/0w89c7np</link>
      <description>&lt;p&gt;Phosphodiesterase 8A (PDE8A) is a 3′,5′-cyclic-nucleotide phosphodiesterase that specifically catalyses the hydrolysis of cAMP to AMP. PDE8A is one of the two isoenzymes of the PDE8 family, the other being PDE8B. These two highly similar proteins have several common features that distinguish them from other cAMP-specific PDEs: they have very high affinity for the substrate cAMP; they are insensitive to the non-specific PDE inhibitor IBMX. They contain a PAS (Per, Arnt and Sim) and a REC (receiver) domain, both of which are observed in many signal transduction proteins. The possible function(s) of the PAS domain in PDE8 is still unknown. &lt;em&gt;PDE8A&lt;/em&gt; mRNA is not expressed in all tissues but has been detected in several and is highest in testis, spleen, small intestine, heart, ovary, colon and kidney. Until early 2009, the lack of specific small-molecule inhibitors slowed the study of the physiological relevance of PDE8A; thus to date many aspects of this PDE's functions (that...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0w89c7np</guid>
      <pubDate>Tue, 14 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Patrucco, Enrico</name>
      </author>
      <author>
        <name>Kraynik, Stephen</name>
      </author>
      <author>
        <name>Beavo, Joseph A</name>
      </author>
    </item>
    <item>
      <title>BARD1</title>
      <link>https://escholarship.org/uc/item/8mc1k7b5</link>
      <description>&lt;p&gt; &lt;/p&gt;&lt;p&gt;BARD1 was originally identified as a protein interacting with BRCA1, the breast cancer predisposition gene product. BARD1, like BRCA1, has an amino-terminal RING-finger domain and carboxy-terminal BRCT domains. In addition, BARD1 has three ankyrin repeats adjacent to the BRCT domains. BARD1 and BRCA1 form a stable heterodimer via their RING-finger domains. BRCA1, like many RING-finger proteins, has E3 ubiquitin ligase activity, which is amplified when in association with BARD1. By contrast, BARD1 alone has no such activity. The binding of BARD1 to BRCA1 stabilizes BRCA1 and, to some extent, BARD1. BARD1 and BRCA1 are co-expressed in most proliferating tissues and are localized to the nucleus. Based mostly on its ubiquitin ligase activity, the BARD1/BRCA1 complex has functions in DNA repair, transcriptional regulation, chromatin condensation, cell-cycle regulation, mitotic spindle formation and cytokinesis. BARD1 is highly conserved, having orthologs in many species....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8mc1k7b5</guid>
      <pubDate>Fri, 10 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Irminger-Finger, Irmgard</name>
      </author>
    </item>
    <item>
      <title>NK1 (substance P) receptor</title>
      <link>https://escholarship.org/uc/item/7fn346j7</link>
      <description>Neurokinin-1 receptor (NK1R), or substance P receptor, is a G protein-coupled receptor (GPCR) that transmits the signal of substance P (SP) and other tachykinins. Upon stimulation by its agonist SP, NK1R has been shown to interact with multiple G proteins, including Gs, Gq/11, Gi/o, G12, and G13. NK1R undergoes a rapid agonist-dependent desensitization, which is mediated by members of G protein receptor kinases (GRKs) and β-arrestins. NK1R is widely distributed in the central and peripheral nervous systems, as well as in the gastrointestinal tract, immune system, and skin. NK1R plays a key role in many physiological and pathophysiological processes, including pain, inflammation, cancer, brain edema, traumatic brain injury, nausea and vomiting, affective disorders, and obesity. Several pharmaceutical companies are actively developing compounds to target NK1R for its therapeutic potential. The first FDA approval for a NK1R antagonist was obtained in 2003 for aprepitant, which is...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7fn346j7</guid>
      <pubDate>Fri, 10 May 2013 00:00:00 +0000</pubDate>
      <author>
        <name>Goldsmith, Laura E</name>
      </author>
      <author>
        <name>Kwatra, Madan M</name>
      </author>
    </item>
  </channel>
</rss>
